Gulf International Bank UK Ltd Sells 5,419 Shares of The Cooper Companies, Inc. $COO

Key Points

• Gulf International Bank UK Ltd reduced its stake in The Cooper Companies, Inc. by 35.0%, selling 5,419 shares, with their holdings valued at $848,000 at the end of the first quarter.
• The Cooper Companies reported $1 billion in revenue for the last quarter, exceeding analyst estimates of $995.12 million, and had a net margin of 10.39%.
• Analysts have varied opinions on the stock, with recent price targets ranging from $90.00 to $96.73, reflecting differing outlooks on the company's growth potential.

Gulf International Bank UK Ltd lessened its stake in shares of The Cooper Companies, Inc. (NASDAQ:COO - Free Report) by 35.0% in the first quarter, according to its most recent filing with the Securities & Exchange Commission. The institutional investor owned 10,062 shares of the medical device company's stock after selling 5,419 shares during the quarter. Gulf International Bank UK Ltd's holdings in Cooper Companies were worth $848,000 at the end of the most recent reporting period.

A number of other hedge funds have also recently made changes to their positions in the company. Zions Bancorporation National Association UT purchased a new position in shares of Cooper Companies during the first quarter worth about $33,000. City Holding Co. bought a new stake in Cooper Companies in the first quarter valued at approximately $34,000. GKV Capital Management Co. Inc. purchased a new stake in Cooper Companies during the 1st quarter valued at $40,000. Larson Financial Group LLC boosted its holdings in shares of Cooper Companies by 1,071.0% during the first quarter. Larson Financial Group LLC now owns 726 shares of the medical device company's stock worth $61,000 after purchasing an additional 664 shares during the period. Finally, HM Payson & Co. grew its position in shares of Cooper Companies by 147.4% in the 1st quarter. HM Payson & Co. now owns 893 shares of the medical device company's stock worth $75,000 after buying an additional 532 shares during the last quarter. 24.39% of the stock is currently owned by hedge funds and other institutional investors.

Cooper Companies Trading Up 2.9%

Shares of NASDAQ:COO traded up $2.1350 during trading on Friday, reaching $75.1750. The company's stock had a trading volume of 382,135 shares, compared to its average volume of 2,146,517. The stock has a market capitalization of $15.03 billion, a PE ratio of 36.48, a price-to-earnings-growth ratio of 1.79 and a beta of 1.00. The company has a current ratio of 2.10, a quick ratio of 1.23 and a debt-to-equity ratio of 0.30. The firm's 50 day simple moving average is $72.07 and its two-hundred day simple moving average is $78.46. The Cooper Companies, Inc. has a 12 month low of $65.00 and a 12 month high of $112.38.

Cooper Companies (NASDAQ:COO - Get Free Report) last posted its quarterly earnings data on Thursday, May 29th. The medical device company reported $0.96 EPS for the quarter, topping the consensus estimate of $0.93 by $0.03. The company had revenue of $1 billion during the quarter, compared to analyst estimates of $995.12 million. Cooper Companies had a net margin of 10.39% and a return on equity of 9.60%. Cooper Companies's quarterly revenue was up 6.3% compared to the same quarter last year. During the same period in the previous year, the firm earned $0.85 earnings per share. Cooper Companies has set its FY 2025 guidance at 4.050-4.110 EPS. On average, research analysts predict that The Cooper Companies, Inc. will post 3.98 EPS for the current fiscal year.

Analyst Ratings Changes

Several analysts have weighed in on the company. BNP Paribas Exane raised Cooper Companies from a "neutral" rating to an "outperform" rating and set a $92.00 price objective on the stock in a research report on Tuesday, July 22nd. UBS Group upgraded shares of Cooper Companies to a "buy" rating in a research note on Tuesday, June 17th. Robert W. Baird decreased their price target on Cooper Companies from $107.00 to $97.00 and set an "outperform" rating for the company in a research note on Friday, May 30th. JPMorgan Chase & Co. reissued a "neutral" rating and set a $76.00 price objective (down from $110.00) on shares of Cooper Companies in a report on Friday, May 30th. Finally, Wall Street Zen downgraded Cooper Companies from a "buy" rating to a "hold" rating in a report on Saturday, July 12th. One research analyst has rated the stock with a Strong Buy rating, nine have given a Buy rating and two have issued a Hold rating to the stock. Based on data from MarketBeat.com, Cooper Companies presently has a consensus rating of "Moderate Buy" and a consensus target price of $96.73.

Cooper Companies Profile

The Cooper Companies, Inc, together with its subsidiaries, develops, manufactures, and markets contact lens wearers. The company operates in two segments, CooperVision and CooperSurgical. The CooperVision segment provides spherical lense, including lenses that correct near and farsightedness; and toric and multifocal lenses comprising lenses correcting vision challenges, such as astigmatism, presbyopia, and myopia in the Americas, Europe, Middle East, Africa, and Asia Pacific.